Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-31

Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) [Phase 4]

View source ↗

Summary

Clinical trial update for abatacept in pemphigus vulgaris (Phase 4) evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Tongji Hospital | Conditions: Pemphigus Vulgaris | Phase 4 | Status: UNKNOWN